Dr Weir discusses the importance of potassium control and strategies to further enable RAAS inhibitor use in patients with CKD and HF.

Earn Credit / Learning Objectives & Disclosures

---

Full URLs:
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/926211?src=mkm_podcast_addon_926211